Armis Advisers’s Cameco CCJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.62M Buy
53,661
+8,189
+18% +$772K 0.39% 41
2026
Q2
$4.43M Buy
45,472
+1,635
+4% +$183K 0.41% 39
2026
Q1
$5.06M Buy
43,837
+816
+2% +$93.4K 0.49% 38
2025
Q4
$4.37M Sell
43,021
-618
-1% -$55.7K 0.49% 33
2025
Q3
$4.4M Buy
43,639
+10,848
+33% +$841K 0.4% 46
2025
Q2
$2.38M Buy
32,791
+5,006
+18% +$267K 0.19% 97
2025
Q1
$1.23M Buy
+27,785
New +$1.31M 0.12% 140

Other funds holding CCJ

Armis Advisers's CCJ Position: Q3 2026 in Review

Armis Advisers increased its Cameco (CCJ) stake by 18% in Q3 2026, buying an estimated $772K and bringing the position to 53,661 shares worth $4.62M. The position accounts for 0.39% of the portfolio, ranked #41.

Armis Advisers first reported a position in CCJ in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.06M in Q1 2026. 255 funds tracked by Wall St. Rank hold CCJ as of Q3 2026.

  • Armis Advisers held 53,661 shares of Cameco worth $4.62M as of Q3 2026.
  • Armis Advisers bought 8,189 Cameco shares in Q3 2026, an estimated $772K.
  • Cameco made up 0.39% of Armis Advisers's portfolio in Q3 2026, its #41 holding.
  • Armis Advisers first reported a position in Cameco in Q1 2025 and has held it in 7 quarters since.
  • Armis Advisers's Cameco position peaked at $5.06M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held Cameco as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.